JPWO2023144341A5 - - Google Patents
Info
- Publication number
- JPWO2023144341A5 JPWO2023144341A5 JP2024544873A JP2024544873A JPWO2023144341A5 JP WO2023144341 A5 JPWO2023144341 A5 JP WO2023144341A5 JP 2024544873 A JP2024544873 A JP 2024544873A JP 2024544873 A JP2024544873 A JP 2024544873A JP WO2023144341 A5 JPWO2023144341 A5 JP WO2023144341A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- nlpd
- protein
- drug according
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2201139.9 | 2022-01-28 | ||
| GBGB2201139.9A GB202201139D0 (en) | 2022-01-28 | 2022-01-28 | Therapeutic agent |
| PCT/EP2023/052076 WO2023144341A1 (en) | 2022-01-28 | 2023-01-27 | Therapeutic agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025503251A JP2025503251A (ja) | 2025-01-30 |
| JP2025503251A5 JP2025503251A5 (https=) | 2026-02-04 |
| JPWO2023144341A5 true JPWO2023144341A5 (https=) | 2026-02-04 |
Family
ID=80621245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544873A Pending JP2025503251A (ja) | 2022-01-28 | 2023-01-27 | 治療薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250241990A1 (https=) |
| EP (1) | EP4469153A1 (https=) |
| JP (1) | JP2025503251A (https=) |
| CN (1) | CN119156222A (https=) |
| AU (1) | AU2023213106A1 (https=) |
| GB (1) | GB202201139D0 (https=) |
| WO (1) | WO2023144341A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119936405A (zh) * | 2025-01-23 | 2025-05-06 | 上海市重大传染病和生物安全研究院 | 血浆IL-1Ra作为生物标志物在儿童脓毒症诊断和预后中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA761627B (en) | 1976-03-16 | 1978-01-25 | C Friedmann | Improvements in or relating to the treatment of arthritis |
| US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| US8153166B2 (en) * | 2006-06-08 | 2012-04-10 | Chih-Hsiung Lin | Composition for prophylaxis or treatment of urinary system infection and method thereof |
| GB201617548D0 (en) * | 2016-10-17 | 2016-11-30 | Linnane Pharma Ab | Novel biological factor |
-
2022
- 2022-01-28 GB GBGB2201139.9A patent/GB202201139D0/en not_active Ceased
-
2023
- 2023-01-27 CN CN202380030569.XA patent/CN119156222A/zh active Pending
- 2023-01-27 EP EP23705488.7A patent/EP4469153A1/en active Pending
- 2023-01-27 JP JP2024544873A patent/JP2025503251A/ja active Pending
- 2023-01-27 WO PCT/EP2023/052076 patent/WO2023144341A1/en not_active Ceased
- 2023-01-27 US US18/833,811 patent/US20250241990A1/en active Pending
- 2023-01-27 AU AU2023213106A patent/AU2023213106A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4965787B2 (ja) | 酵素阻害剤の組み合わせを含有する製剤とその使用 | |
| JP2024075713A5 (https=) | ||
| JP2010202663A (ja) | 非神経障害性疼痛を処置するための方法 | |
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2007522248A (ja) | てんかんおよび他のｃｎｓ障害の処置のための、ｎｍｄａレセプターアンタゴニストと抗てんかん薬との組み合わせ | |
| JP2021519764A (ja) | 線維性疾患を処置する方法 | |
| JP2005533766A5 (https=) | ||
| JP2006513184A5 (https=) | ||
| JP2005506345A5 (https=) | ||
| JP2018531945A (ja) | 免疫系を刺激するためのペプチドの使用 | |
| US6384083B1 (en) | Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals | |
| TWI351950B (en) | Use of (halobenzyloxy) benzylamino-propanamides fo | |
| JP2025533648A (ja) | 化膿性汗腺炎を治療するための方法および組成物 | |
| SK138095A3 (en) | Transdermal therapeutic system for the administration of serotonin agonists | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2002519391A5 (https=) | ||
| RU2011101771A (ru) | Педиатрические композиции для лечения рассеянного склероза | |
| CA2463987A1 (en) | Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism | |
| JP2872809B2 (ja) | モノシアロガングリオシドｇｍ▲下１▼またはその誘導体を含有する，パーキンソン病の治療に適する医薬組成物 | |
| JPWO2023144341A5 (https=) | ||
| US6077839A (en) | Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists | |
| CA2492378A1 (en) | Modified amino acid for the inhibition of platelet aggregation | |
| JPH08501069A (ja) | 強心剤と一酸化窒素合成抑制剤の併用による病的低血圧の治療 | |
| US7153826B2 (en) | Treatment of rosacea | |
| WO2004026296A1 (ja) | 抗ストレス性疾患組成物 |